Tuesday, May 01, 2018 8:38:07 PM
First off, AMDA will be on Nasdaq Regsho Circuit Breaker again tomorrow. Big Bears said "it's not naked short sale"; there is no such thing as "share price manipulation" using naked shorting. sure sure sure...
BEARS say there is "No naked short", then why there is such thing as "Failed to deliver", see below data:
https://www.sec.gov/data/foiadocsfailsdatahtm
SETTLEMENT DATE|CUSIP|SYMBOL|QUANTITY (FAILS)|COMPANY NAME|CLOSING PRICE ON PREVIOUS DAY
Jan 2018
20180102|023435407|AMDA|14745|AMEDICA CORP COM PAR $0.01|3.27
20180103|023435407|AMDA|3008|AMEDICA CORP COM PAR $0.01|3.87
20180104|023435407|AMDA|2140|AMEDICA CORP COM PAR $0.01|3.76
20180105|023435407|AMDA|9817|AMEDICA CORP COM PAR $0.01|3.56
20180108|023435407|AMDA|7543|AMEDICA CORP COM PAR $0.01|3.59
20180109|023435407|AMDA|2864|AMEDICA CORP COM PAR $0.01|3.61
20180110|023435407|AMDA|1325|AMEDICA CORP COM PAR $0.01|3.56
20180111|023435407|AMDA|143|AMEDICA CORP COM PAR $0.01|3.57
20180112|023435407|AMDA|143|AMEDICA CORP COM PAR $0.01|3.59
20180116|023435407|AMDA|143|AMEDICA CORP COM PAR $0.01|3.55
20180117|023435407|AMDA|143|AMEDICA CORP COM PAR $0.01|3.60
20180118|023435407|AMDA|327|AMEDICA CORP COM PAR $0.01|3.48
20180119|023435407|AMDA|11405|AMEDICA CORP COM PAR $0.01|3.48
20180122|023435407|AMDA|8021|AMEDICA CORP COM PAR $0.01|3.49
20180123|023435407|AMDA|143|AMEDICA CORP COM PAR $0.01|3.38
20180124|023435407|AMDA|143|AMEDICA CORP COM PAR $0.01|3.42
20180125|023435407|AMDA|368|AMEDICA CORP COM PAR $0.01|3.39
20180126|023435407|AMDA|143|AMEDICA CORP COM PAR $0.01|3.37
20180131|023435407|AMDA|664|AMEDICA CORP COM PAR $0.01|3.32
------------------------------------------------------------------------
Feb 2018
20180209|023435407|AMDA|91|AMEDICA CORP COM PAR $0.01|2.66
20180212|023435407|AMDA|639|AMEDICA CORP COM PAR $0.01|2.67
20180216|023435407|AMDA|1779|AMEDICA CORP COM PAR $0.01|2.58
------------------------------------------------------------------------
Mar 2018
20180301|023435407|AMDA|85|AMEDICA CORP COM PAR $0.01|2.12
20180302|023435407|AMDA|90|AMEDICA CORP COM PAR $0.01|2.04
20180306|023435407|AMDA|2115|AMEDICA CORP COM PAR $0.01|2.00
20180308|023435407|AMDA|734830|AMEDICA CORP COM PAR $0.01|2.28
20180309|023435407|AMDA|237597|AMEDICA CORP COM PAR $0.01|2.20
0180312|023435407|AMDA|41466|AMEDICA CORP COM PAR $0.01|2.07
20180314|023435407|AMDA|4664|AMEDICA CORP COM PAR $0.01|1.98
20180315|023435407|AMDA|3238|AMEDICA CORP COM PAR $0.01|1.92
20180316|023435407|AMDA|416|AMEDICA CORP COM PAR $0.01|1.86
20180319|023435407|AMDA|444|AMEDICA CORP COM PAR $0.01|1.71
20180320|023435407|AMDA|349|AMEDICA CORP COM PAR $0.01|1.80
20180321|023435407|AMDA|449|AMEDICA CORP COM PAR $0.01|1.75
20180322|023435407|AMDA|1080|AMEDICA CORP COM PAR $0.01|1.74
20180327|023435407|AMDA|4223|AMEDICA CORP COM PAR $0.01|1.71
20180328|023435407|AMDA|4955|AMEDICA CORP COM PAR $0.01|1.55
20180329|023435407|AMDA|31840|AMEDICA CORP COM PAR $0.01|1.52
------------------------------------------------------------------------
Apr 2018 (First Half)
20180402|23435407|AMDA|3886|AMEDICA CORP COM PAR $0.01|1.52
20180403|23435407|AMDA|3768|AMEDICA CORP COM PAR $0.01|1.36
20180406|23435407|AMDA|2197|AMEDICA CORP COM PAR $0.01|1.46
20180412|23435407|AMDA|2029|AMEDICA CORP COM PAR $0.01|1.32
20180413|23435407|AMDA|195|AMEDICA CORP COM PAR $0.01|1.29
& of course they can manipulate this data on how they report to SEC & FIRNA as well - as we know the market is so corrupted. The Big Bears triggered the Regsho Circuit Breaker & now all show up full house to convince the REAL BULLs to give up the shares by spreading misinfo to create panic-selling. Any sane person can clearly see the orchestration of attack on the share price. I really want to see if Japan Clearance & M&A come first or all these BS spinning come first:
1. OTC oh yeah, R/S oh yeah...
2. Out of $$$ oh yeah- COH est. is around $2.2 mils & the cash burn in 3 month of Q4'2017 was less than $500K (this is not even including the sale rampled up - but yet to book revenue - or else the burn should be way way down)
3. They can't pay the creditors back - 3 notes holder balance dropped from $3.2 mils to $2.5 mils (info. is on S-1 & S-1/A). There isn't any letter of default from any note holders!!! They are slowly paying them down. Letter of consents can be obtained in case of M&A deal sign. I covered this subject also.
4. etc.
Set of words warned by SEC to retail investors:
https://www.sec.gov/rules/final/2010/34-61595.pdf
https://www.sec.gov/fast-answers/answerstmanipulhtm.html
Who is actually manipulate share price??? So obvious right?
Regarding the S-1, beside the voting control as a backup plan, AMDA might have unfriendly acquirer(s) trying to buy them for cheap!!! Could be anti-takeover mechanism they are implementing. This is one of the BEARs' big plan to force them to file the S-1...look at the size of the offering...doesn't even make sense! Also, the preferred shares conversion price is not yet set (also, based on a conversion formula):
Even the warrants conversion price is not yet set as well.
Zimmer keeps jerking around...lmao...what if this tech really fall into the competitor's hands later? Only god can help them then.
& now...
Let's spend a little time to talk about some #s:
Boston showed Sonny everyone that Sonny invested $1.6 millions so far in AMDA, right?
Would 5 times return on his invested fund makes him happy? maybe...
So $1.6 mil X 5 = $8 mils (Sonny portion from 10% COC package)
AMDA has a few executives on the Change of Control package (10% of the Buyout amount)
So let's say $8 mils X 5 executives = $40 mils (which is 10% of the BO price)
so at the minimum, the BO price has to be $400 mils for Sonny to multiply his invested $ five folds.
I meant upfront not including the CVR (milestone payments).
or do you really think Sonny will sell this company for $10 mils (double the current market cap). If so, how much will be his cut???
10% of $10 mils = $1 mils, then divided by 5 (5 executives) & wow $200K will be Sonny's cut!
WTF, isn't it? So Sonny will not bow down to low BO offer.
There must be a minimum & reasonable amount Zimmer must pay to own this Si3N4 tech! NO WAY that others big players in the industries let Zimmer own this tech for cheap...NO GOD DAMN WAY.
=======CFO & ICW & Restatements again WTF =========
Regarding the CFO got fired or laid off? If he made mistake & got canned, where is the new CFO then??? It was part of the "trimming fat" to improve the books before M&A man. I already covered all the details - any sane person can see how clean the EPS looks now compares to previous years. Also, how long since AMDA doesn't have a CFO & IR team - since 2016, right? The recent jobs hiring in past 5 months were just for position in production! Hence the sale was/is ramping up:
https://www.indeed.com/cmp/Amedica-Corp/reviews?fcountry=ALL
The ones posted the other day is gone now. The most 2 recent ones before that was 1 for product manager & the other was Quality Control position...all point to higher sale = higher production staffing & NOT G&A staffing!
Boston, you need not argue w/ the BEARs about the Interal Control Weakness Disclosure man. I already showed examples regarding ICW disclosure of failed merger (Ticker HOPE) vs. successful merger (Ticker TERP). The Bears will always spin their own BS anyway...like nothing going on between Zimmer & AMDA...while mountain of evidences showing Zimmer's finger prints are all over AMDA!!! Also, good finding on your part on Zimmer's 2016 ICW disclosure.
Restatements? LMAO...Bears are still grasping at this? I posted enough examples already.
=============Japan Clearance Examples==================
https://www.businesswire.com/news/home/20161114005172/en/
(November 14, 2016 06:00 AM Eastern Standard Time)
*** June 2016 = Submitted App. & November 2016 = Signed deals ***
&
https://www.mpo-mag.com/contents/view_breaking-news/2017-04-11/cardiovascular-systems-receives-us-japanese-approvals-for-diamondback-360-coronary-micro-crown/
*** April 2017 = Approval - TOOK THEM 10 MONTHS & 2 WEEKS***
As you can see there is no restriction to sign deals pending approval in Japan, they are withholding the deals signing & the disclosure of MAH in Japan for some strategic reason (I would say shady Zimmer). In Japan, you must have MAH in order to submit clearance application. So obvious Zimmer is the MAH as well.
I also covered this in past posts - consultation clinical data submitted in Summer 2016; application clinical data submitted in May or June 2017.
https://twitter.com/AmedicaCorp (shows ISO image for QMS process in late July)
Looks like we are at the 10th month in Japan Clearance process.
https://www.emergogroup.com/blog/2016/08/japanese-mhlw-takes-steps-toward-aligning-iso-134852016-its-own-qms-requirements (QMS process requires ISO version 2016)
https://www.pmda.go.jp/files/000203966.pdf (check the QMS timeline)
Link below shows QMS & Regulartory Review & Approval Process are simutaneously happen:
https://www.pmda.go.jp/english/review-services/outline/0001.html
1 out of 4 Japaneses is an edlerly over 65 years old = Huge Market!
https://en.wikipedia.org/wiki/Demography_of_Japan
https://www.pacificbridgemedical.com/regulatory-services/medical-device-pharmaceutical/local-agent-representation/japan/
https://www.slideshare.net/emergogroup/japan-medical-device-regulatory-approval-process-67299691
slide 41/59
https://www.pacificbridgemedical.com/regulatory-services/medical-device-pharmaceutical/local-agent-representation/japan/
Boston, instead of wasting your time & energy to fight with "XYZdoyourdd0123", lol...please try to look into this type of clearances in Japan & find the timeline of their approvals:
http://www.odtmag.com/contents/view_breaking-news/2017-06-22/exactechs-knee-and-hip-systems-granted-japanese-approval
http://investors.alphatecspine.com/static-files/52213b4e-20d8-4122-b613-72927c392394
=========================Zimmer Q1'2018 CC=====================
1. Their investors are growing weary & losing patience on their BS.
2. Their investors kept pressure them on "show me the god-damn new products already"...& of course they jerk around that...lol.
3. Boston, Warsaw issue is about their Trabecular Knee products, the issues with FDA since 2016..greatly affect their inventory. I believe Kyrocera will manufacture the Si3N4 products for Zimmer later.
4. Bryan isn't happy about their Spine performance (even though LDRH & Biomet are now fully integrated). Initially, they need AMDA's Spine products to help them to score in Spine Market & the Tech to develop other products in near future - Plans for full offense & full growth in their business - Zimmer has big plans, but they need to fully own Si3N4 tech first - in order to complete these plans they laid out.
5. EPS dropped 42% in Q1'2018 compares to Q1'2017 & their investors aren't too happy about it.
6. Expecting to launch new weapons (new products) to surprise the investors in second half 2018 (even M&A is announced now, it will be closed after 60 days anyway - 2H'2018)
7. etc...
& Boston already covered some other info.
Every REAL BULLs should read Zimmer's CC transcript.
It looks like Japan Clearance is what they are waiting on & Ash mentioned about this a few times back then.
Also, Q1'2018 ER is due on May 15th, 2018. Can't wait to see how long does it really take to book the revenue from Q4'2017. Boston said 1 year????? I highly doubt it takes 12 months to book revenue after they implanted the units.
=========================================
Like always, the Bears say no M&A & not w/ Zimmer,
IT MEANS IT WILL BE M&A with Zimmer.
The $4 plus millions market cap is comical to really look at...really?...lol...manipulation as its finest.
Recent SINT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 01:10:13 PM
- SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024 • GlobeNewswire Inc. • 05/23/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 09:20:34 PM
- SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT • GlobeNewswire Inc. • 04/29/2024 01:14:20 PM
- SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock • GlobeNewswire Inc. • 04/03/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/29/2024 08:00:00 PM
- SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock • GlobeNewswire Inc. • 03/25/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET • GlobeNewswire Inc. • 02/21/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 02:00:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:12:54 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/07/2024 09:42:32 PM
- SINTX Technologies Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 02/02/2024 07:33:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 11:30:20 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/01/2024 10:14:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/01/2024 05:15:22 AM
- SINTX Technologies Announces Pricing of $4.0 Million Public Offering • GlobeNewswire Inc. • 01/31/2024 02:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 11:05:14 AM
- SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY • GlobeNewswire Inc. • 01/30/2024 09:01:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:05:13 PM
- SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE • GlobeNewswire Inc. • 01/23/2024 02:00:00 PM
- SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:10:37 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM